AU2003291245A1 - 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml) - Google Patents
4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml)Info
- Publication number
- AU2003291245A1 AU2003291245A1 AU2003291245A AU2003291245A AU2003291245A1 AU 2003291245 A1 AU2003291245 A1 AU 2003291245A1 AU 2003291245 A AU2003291245 A AU 2003291245A AU 2003291245 A AU2003291245 A AU 2003291245A AU 2003291245 A1 AU2003291245 A1 AU 2003291245A1
- Authority
- AU
- Australia
- Prior art keywords
- quinolinecarbonitriles
- cml
- anilino
- treatment
- myelogenous leukemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2003/035322 WO2005047259A1 (en) | 2003-11-06 | 2003-11-06 | 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2004289243A Division AU2004289243B2 (en) | 2003-11-06 | 2004-11-03 | 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (CML) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003291245A1 true AU2003291245A1 (en) | 2004-06-06 |
| AU2003291245A8 AU2003291245A8 (en) | 2005-06-06 |
Family
ID=34589300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003291245A Abandoned AU2003291245A1 (en) | 2003-11-06 | 2003-11-06 | 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml) |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003291245A1 (en) |
| WO (1) | WO2005047259A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2449197T5 (en) * | 2005-07-01 | 2022-04-28 | Wyeth Llc | Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the same |
| US20100152198A1 (en) * | 2006-04-07 | 2010-06-17 | Manley Paul W | Use of c-src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia |
| CN102070524A (en) * | 2011-01-12 | 2011-05-25 | 无锡好芳德药业有限公司 | Method for preparing 3-cyano-4-halogenated quinoline derivatives |
| US9776970B2 (en) | 2014-02-20 | 2017-10-03 | Apotex Inc. | Bosutinib forms and preparation methods thereof |
| WO2017029584A1 (en) * | 2015-08-19 | 2017-02-23 | Sun Pharmaceutical Industries Limited | Amorphous form of bosutinib |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA73073C2 (en) * | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Substituted 3-cyan chinolines |
| AR035851A1 (en) * | 2000-03-28 | 2004-07-21 | Wyeth Corp | 3-CIANOQUINOLINS, 3-CIANO-1,6-NAFTIRIDINES AND 3-CIANO-1,7-NAFTIRIDINS AS INHIBITORS OF PROTEIN KINASES |
-
2003
- 2003-11-06 WO PCT/US2003/035322 patent/WO2005047259A1/en active Application Filing
- 2003-11-06 AU AU2003291245A patent/AU2003291245A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003291245A8 (en) | 2005-06-06 |
| WO2005047259A1 (en) | 2005-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL175424A0 (en) | 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml) | |
| EP1638508A4 (en) | Shunt for the treatment of glaucoma | |
| EP1705989B8 (en) | Substituted arylpyrazoles as parasiticidal agents | |
| AU2003258145A1 (en) | Substituted phenylindoles for the treatment of hiv | |
| HK1096621A1 (en) | Parasiticidal composition | |
| AU2005254779A8 (en) | Well treatment | |
| GB2405789B (en) | Patient table | |
| AU2003291886A1 (en) | Thiophenederivatives for the treatment of flavivirus infections | |
| AU2003275870A1 (en) | Fold-down table | |
| AU2003291245A1 (en) | 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml) | |
| GB2404587B (en) | Parasiticidal composition | |
| AU2003295163A1 (en) | Composition for the treatment of hiv or aids | |
| AU2002304883A1 (en) | Device for the treatment of tumours | |
| EP1365033A4 (en) | Method of molecular diagnosis of chronic myelogenous leukemia | |
| AU154131S (en) | Table | |
| AU2003240174A1 (en) | Compositions for the treatment of edematous-firbrosclerotic panniculopathy | |
| GB0313630D0 (en) | Compositions for the enhanced treatment of depression | |
| AU2003292682A1 (en) | Catheter | |
| AU2003291882A1 (en) | Pharmaceutical combinations and methods for the treatment of leukemia | |
| AU157684S (en) | Router table | |
| AU2003902551A0 (en) | Airhandler surface treatment | |
| AU2003245579A1 (en) | Treatment of patients with chronic lymphocytic leukemia | |
| AU157347S (en) | Treatment table | |
| GB2398266B (en) | Table | |
| AU2003906719A0 (en) | Innovative billiad table |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TH | Corrigenda |
Free format text: IN VOL 19, NO 28, PAGE(S) 1861 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME WYETH, APPLICATION NO. 2003291245, UNDER INID (43) CORRECT THE DATE TO READ 06.06.2005 |
|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |